Experts Recommend Just One BioNTech Jab For Teens

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2021-09-15 HKT 21:06

Share this story

facebook

  • Government advisor Lau Yu-lung says the new advice strikes a balance between the vaccine’s risks and benefits. File photo: RTHK

    Government advisor Lau Yu-lung says the new advice strikes a balance between the vaccine’s risks and benefits. File photo: RTHK

Expert advisers to the government on Wednesday changed their guidance on Hong Kong teenagers getting vaccinated against Covid-19, saying they only need one BioNTech jab instead of two.

The change comes after more than 30 teenagers suffered inflammation of the heart as a suspected side effect of the jab, since the government started giving BioNTech vaccine to adolescents aged between 12 and 17 from June.

Professor Lau Yu-lung, who chairs a scientific committee advising the government on its vaccination programme, said latest statistics showed the side effect was more prevalent than originally thought.

He said, therefore, experts decided it’s now better for teenagers to get only one dose, as this would greatly reduce the chance of heart inflammation.

Lau added that given Hong Kong hasn’t had any local Covid-19 cases for some time, one dose of the vaccine should offer adequate protection.

He said the new advice strikes a balance between the vaccine’s risks and benefits.

“At the time the decision was made based on the best available evidence. If you view it in this context, obviously it was not a mistake at that time to recommend two doses,” he said.

“But if you use the current understanding in the context of Hong Kong… we need to have the courage to come out to the public and do the proper risk communication that we’re going to switch from two doses to one dose.”

But Lau said teenagers should get two doses if, for example, they are going to study abroad, for example in Europe or the US, which have seen a lot of Covid-19 infections.

The experts also discussed when the general public as well as immunocompromised people would need a booster shot.

The experts said they needed more information on the matter before making a decision.

David Hui, a professor of respiratory medicine at the Chinese University of Hong Kong, said another factor they needed to consider was when Hong Kong would lift its border restrictions.

“Currently, we’re doing fine. There’re no cases. But when do we need to live with the virus? We need to be guided. So once we see the light, perhaps two months before opening the border, we start vaccinating the high-risk groups,” he said.

He said the city’s top priority should be giving the jabs to as many elderly people as possible, as the vaccine take-up rate among them is low.

RECENT NEWS

Airwallex Yield Service Goes Live In Hong Kong

Airwallex has officially launched Airwallex Yield in Hong Kong on 18 June 2025, which it advertises to offer businesses... Read more

Alipay And Rokid Launch AR Glasses Payment Function For In-Store Payments In China

Rokid has launched its latest augmented reality device, Rokid Glasses. In China, the Rokid AR payment glasses support i... Read more

InvestHKs Gulf Cooperation Council Fintech Visit Spurs Strategic Partnerships

Invest Hong Kong (InvestHK) reinforced its role as a global business hub through a strategic visit to the Gulf Cooperat... Read more

Can Crypto Firms Catch Up On Compliance Gaps As Regulations Evolve?

As crypto adoption accelerates, regulators are ramping up enforcement of the Financial Action Task Force’s (FATF) Tra... Read more

OneDegree Eyes Global Growth With Middle East, Europe And Africa Next

Hong Kong virtual insurer OneDegree has made significant progress in the Middle East, securing 20 contracts since enter... Read more

IFAST Introduces Bondsupermart Live With Stock-like Trading Experience For Bond Investors

To address structural inefficiencies in bond markets, iFAST introduced Bondsupermart Live, a digital bond trading servi... Read more